NIH Locks Doors for Secret Alzheimer's Grant Huddle
Published Date: 7/21/2025
Notice
Summary
The Center for Scientific Review is holding private virtual meetings in August 2025 to review important grant applications about Alzheimer's and aging research. These closed sessions protect sensitive info like personal details and trade secrets. Scientists and researchers applying for funding should note these dates as they impact which projects get support.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Closed NIH Grant Review Dates
If you are a scientist or researcher who applied for NIH funding in Alzheimer's disease or aging research, your grant applications will be reviewed and evaluated in closed meetings on August 19, 2025 (9:00 a.m.–6:00 p.m.) and August 20–21, 2025 (10:00 a.m.–6:00 p.m.). The notices name panels for Career Development Review in Alzheimer’s Disease and for Collaborative Applications in Aging Research.
Confidentiality Protections for Applications
The meetings are closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information of individuals associated with the grant applications.
Virtual Format and Contact Information
Both panels are listed as virtual meetings. Contact persons are provided: Kristin L. McNally, Ph.D. (Scientific Review Officer) and Bo-Shiun Chen, Ph.D. (Scientific Review Officer) with the listed addresses, phone, and email for inquiries about the reviews.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-13583, Marine Mammals; File No. 28931
Passion Planet from the UK just got a permit to take cool photos of marine mammals for both business and learning purposes. This means they can snap pictures of whales, dolphins, and seals while sharing knowledge about these amazing creatures. No big money changes or deadlines were mentioned, so it’s all about capturing nature’s stars responsibly!
Next: 2025-13585, Center for Scientific Review; Amended Notice of Meeting
Heads up! The NIH’s Center for Scientific Review changed the contact person for their August 7, 2025 meeting about brain and blood research. If you were reaching out to Eric Tucker, now you’ll want to contact Dr. Jacek Topczewski instead. This meeting is still closed to the public and won’t affect any funding or timing beyond this update.